KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD.

Altre lingue Kubota Pharmaceutical Holdings Co., Ltd.

Azioni

4596

JP3266500002

Mercato chiuso - Japan Exchange Altri mercati azionari 08:00:00 16/07/2024			Variaz. 5gg	Var. 1 gen.
75 ^JPY	+1,35%		0,00%	-6,25%

22/03	Kubota Pharmaceutical rettifica i risultati finanziari del 2023 a seguito di una rivalutazione	MT
14/02	Kubota Pharmaceutical Holdings Co., Ltd. Riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Kubota Pharmaceutical Adjusts 2023 Financial Results Following Reevaluation	22/03
Kubota Pharmaceutical Holdings Co., Ltd. Restates Consolidated and Non-Consolidated Financial Results for the Fiscal Year Ended December 31, 2023	21/03
Kubota Pharmaceutical Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	14/02
Kubota Pharmaceutical Holdings Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	14/11
Kubota Pharmaceutical Holdings Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	10/08/23
Kubota Pharmaceutical Holdings Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
Kubota Pharmaceutical Group Launches Its Unique Kubota Glass Technology Aiming to Revolutionize Myopia Management	24/02/23
Kubota Pharmaceutical Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	14/02/23
Kubota Pharmaceutical Holdings Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	11/11/22
Kubota Pharmaceutical Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022	11/11/22
Kubota Pharmaceutical Holdings Co., Ltd. announced that it expects to receive ¥3.1 million in funding from Barclays Bank PLC, Investment Arm	15/08/22
Kubota Pharmaceutical Holdings Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	12/08/22
Kubota Pharmaceutical Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022	12/08/22
Kubota Pharmaceutical Holdings Co., Ltd. Announces Database Lock for Phase 3 Clinical Trial of Emixustat in Patients with Stargardt Disease and Expected Release of Top-Line Results in August 2022	27/07/22
Kubota Pharmaceutical Holdings Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	13/05/22
Kubota Pharmaceutical Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022	13/05/22
Kubota Pharmaceutical Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022	14/02/22
Kubota Pharmaceutical Holdings Co., Ltd. Provides Consolidated Financial Guidance for the Year Ending December 31, 2021	12/11/21
Kubota Pharmaceutical : Summary of Financial Results for the second quarter 2021	12/08/21
Kubota Pharmaceutical : Consolidated Financial Results for the Six Months Ended June 30, 2021(under IFRS)	12/08/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Kubota Pharmaceutical Holdings Co., Ltd.

Azioni

4596

JP3266500002

Altre lingue

Filtri